TD Private Client Wealth LLC raised its stake in shares of UBS Group AG (NYSE:UBS – Free Report) by 3.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 12,813 shares of the bank’s stock after purchasing an additional 394 shares during the period. TD Private Client Wealth LLC’s holdings in UBS Group were worth $396,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Coldstream Capital Management Inc. grew its stake in shares of UBS Group by 8.7% during the 3rd quarter. Coldstream Capital Management Inc. now owns 24,863 shares of the bank’s stock valued at $769,000 after acquiring an additional 1,980 shares during the period. Continuum Advisory LLC lifted its holdings in UBS Group by 41.6% during the third quarter. Continuum Advisory LLC now owns 1,532 shares of the bank’s stock valued at $49,000 after purchasing an additional 450 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of UBS Group in the third quarter worth approximately $69,440,000. Groupama Asset Managment increased its stake in shares of UBS Group by 107.1% in the third quarter. Groupama Asset Managment now owns 121,007 shares of the bank’s stock worth $3,740,000 after purchasing an additional 62,579 shares in the last quarter. Finally, Dorsey Wright & Associates increased its stake in shares of UBS Group by 12.3% in the third quarter. Dorsey Wright & Associates now owns 141,675 shares of the bank’s stock worth $4,380,000 after purchasing an additional 15,570 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on UBS shares. StockNews.com upgraded shares of UBS Group from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Bank of America started coverage on UBS Group in a research report on Thursday, September 19th. They issued a “neutral” rating on the stock. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.
UBS Group Trading Down 0.5 %
UBS Group stock opened at $31.86 on Friday. The company has a debt-to-equity ratio of 3.87, a current ratio of 1.05 and a quick ratio of 1.05. The firm’s 50 day moving average price is $32.01 and its 200-day moving average price is $30.89. UBS Group AG has a 1 year low of $26.00 and a 1 year high of $33.34. The stock has a market cap of $102.16 billion, a P/E ratio of 26.55 and a beta of 1.14.
UBS Group (NYSE:UBS – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The bank reported $0.43 EPS for the quarter, topping the consensus estimate of $0.28 by $0.15. The business had revenue of $19.31 billion for the quarter, compared to analysts’ expectations of $11.20 billion. UBS Group had a net margin of 5.13% and a return on equity of 4.69%. During the same quarter in the previous year, the company earned ($0.24) EPS. On average, equities analysts predict that UBS Group AG will post 1.73 earnings per share for the current fiscal year.
UBS Group Company Profile
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions.
Read More
- Five stocks we like better than UBS Group
- What Are the FAANG Stocks and Are They Good Investments?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a support level?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for UBS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBS Group and related companies with MarketBeat.com's FREE daily email newsletter.